Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for imidazo 1, 2- a] pyridine
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
- L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
Most Relevant Literature
- Imidazo[1,2-a]pyridines susceptible to excited state intramolecular proton transfer: one-pot synthes…
- Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, …
- A base promoted cyclization of N-propargylaminopyridines. Synthesis of imidazo[1,2-a]pyridine deriva…
- Design and biological evaluation of imidazo[1,2-a]pyridines as novel and potent ASK1 inhibitors.
- Molecular characterization of EP6--a novel imidazo[1,2-a]pyridine based direct 5-lipoxygenase inhibi…
Most Relevant Clinical Trials
- YL-13027 in Patients With Advanced Solid Tumors
- A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone an…
- Psychosis-Associated Neuroinflammation in Schizophrenia
- Tomivosertib With Azacitide and Venetoclax for the Treatment of Patients With Newly Diagnosed Acute …
- Lonafarnib and Temozolomide in Treating Patients With Glioblastoma Multiforme That Is Recurrent or D…
